154 related articles for article (PubMed ID: 26767044)
1. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial.
Ko HL; Wang YS; Fong WL; Chi MS; Chi KH; Kao SJ
Thorac Cancer; 2014 Nov; 5(6):500-8. PubMed ID: 26767044
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cui Y; Miao C; Hou C; Wang Z; Liu B
Front Oncol; 2020; 10():1436. PubMed ID: 32974161
[No Abstract] [Full Text] [Related]
3. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Yi J; Ren L; Wu J; Li W; Zheng X; Du G; Wang J
Ann Transl Med; 2019 Aug; 7(16):380. PubMed ID: 31555694
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.
Shi X; Wang J; Dai S; Qin L; Zhou J; Chen Y
Onco Targets Ther; 2020; 13():12881-12891. PubMed ID: 33364782
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling.
Jiang H; Tang JY; Xue D; Chen YM; Wu TC; Zhuang QF; He XZ
Cancer Cell Int; 2021 Jan; 21(1):41. PubMed ID: 33430855
[TBL] [Abstract][Full Text] [Related]
7. Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer.
Shen HY; Wei FZ; Liu Q
World J Clin Cases; 2021 Jun; 9(16):3880-3894. PubMed ID: 34141744
[TBL] [Abstract][Full Text] [Related]
8. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer.
Guo Q; Liu XL; Jiang N; Zhang WJ; Guo SW; Yang H; Ji YM; Zhou J; Guo JL; Zhang J; Liu HS
Am J Cancer Res; 2022; 12(11):4904-4929. PubMed ID: 36504892
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study.
Hilbert M; Kuzman P; Mueller WC; Meixensberger J; Nestler U
Sci Rep; 2022 Oct; 12(1):16981. PubMed ID: 36216850
[TBL] [Abstract][Full Text] [Related]
10. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
11. [Expression of high mobility group box-1 in the lung tissue and serum of patients with pulmonary tuberculosis].
Yang XM; Yang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):497-500. PubMed ID: 24262084
[TBL] [Abstract][Full Text] [Related]
12. The Mean ApoC1 Serum Level in Postoperative Samples from Neurosurgical Patients Is Lower than in Preoperative Samples and during Chemotherapy.
Hilbert M; Kuzman P; Mueller WC; Nestler U
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101402
[TBL] [Abstract][Full Text] [Related]
13. APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer.
Yang S; Du J; Wang W; Zhou D; Xi X
BMC Cancer; 2024 Mar; 24(1):364. PubMed ID: 38515073
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.
Su WP; Sun LN; Yang SL; Zhao H; Zeng TY; Wu WZ; Wang D
J Biochem Mol Toxicol; 2018 May; 32(7):e22158. PubMed ID: 29719090
[TBL] [Abstract][Full Text] [Related]
15. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CI knock-out mice display impaired memory functions.
Berbée JF; Vanmierlo T; Abildayeva K; Blokland A; Jansen PJ; Lütjohann D; Gautier T; Sijbrands E; Prickaerts J; Hadfoune M; Ramaekers FC; Kuipers F; Rensen PC; Mulder M
J Alzheimers Dis; 2011; 23(4):737-47. PubMed ID: 21157034
[TBL] [Abstract][Full Text] [Related]
17. [Early acute liver injury in paraquat poisoning rats].
Guo H; Gao K; Luo L; Deng Q; Zhang Y; Luo J; Liu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):374-8. PubMed ID: 24912633
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive potential molecular biomarkers in colon cancer.
Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
[TBL] [Abstract][Full Text] [Related]
19. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and genomic analyses suggest the association of apolipoprotein C1 with abdominal aortic aneurysm.
Moxon JV; Liu D; Moran CS; Crossman DJ; Krishna SM; Yonglitthipagon P; Emeto TI; Morris DR; Padula MP; Mulvenna JP; Rush CM; Golledge J
Proteomics Clin Appl; 2014 Oct; 8(9-10):762-72. PubMed ID: 24591149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
